Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Dosage Regimen: Individualization

Dosage Regimen: Individualization

Individualization in dosing regimens is the customization of medication doses for individual patients. Its necessity arises from the goal of maximizing therapeutic benefits while minimizing risks. This approach is pivotal because human responses to drugs can vary widely; what is effective for one person may be inadequate or excessive for another. Interpatient (intersubject) variability refers to differences in drug responses between individuals, while intrapatient (intrasubject) variability...

Treatment Resistent Cancers

Treatment Resistent Cancers

Drug Therapy

Drug Therapy

The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications

Therapeutic Drug Monitoring: Affecting Factors

Therapeutic Drug Monitoring: Affecting Factors

Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Treatment and Survival Outcomes for Indigenous and Non-Indigenous Australians Within the Victorian Lung Cancer Registry: A Retrospective Cross-Sectional Cohort Study.

The Medical journal of Australia·2026

Same author

Prognostic Value of Liver Metastases and KRAS Mutations in Patients With Metastatic Colorectal Cancer: A Pooled Analysis of Third-Line Placebo-Controlled Trials From the ARCAD CRC Database.

Clinical colorectal cancer·2026

Same author

Open Versus Hybrid and Total Minimally Invasive Transthoracic Ivor Lewis Esophagectomy Following Neoadjuvant FLOT Chemotherapy: An Australian and New Zealand Cohort Study.

World journal of surgery·2026

Same author

Total versus subtotal gastrectomy following neoadjuvant flot chemotherapy for distal diffuse gastric adenocarcinoma: an international cohort study.

Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association·2026

Same author

Sex differences in efficacy and toxicity of first-line treatment of metastatic colorectal cancer: An analysis of 18,041 patients in the ARCAD CRC database.

European journal of cancer (Oxford, England : 1990)·2026

Same author

Global Quantitative Dynamics and Early Warning Signals of Hepatocellular Carcinoma: Integrating Theoretical Modeling with Experimental Validation.

The journal of physical chemistry. B·2026

Same journal

Joint Cancer Nurses Society of Australia-Clinical Oncology Society of Australia Position Statement on the Contribution of Nurses to Cancer Survivorship Care in Australia.

Asia-Pacific journal of clinical oncology·2026

Same journal

Ki-67 Dynamics and Biomarker Conversion as Prognostic Factors in Residual Breast Cancer.

Asia-Pacific journal of clinical oncology·2026

Same journal

Impact of RAS/RAF Mutations on Metastatic Treatment Response Following Total Neoadjuvant Therapy in Patients With Stage IV Rectal Cancer.

Asia-Pacific journal of clinical oncology·2026

Same journal

Comparative Real-World Safety Profiles of Fibroblast Growth Factor Receptor Inhibitors: A Pharmacovigilance Study.

Asia-Pacific journal of clinical oncology·2026

Same journal

Evaluation of a Modified Proprietary Electronic Patient Reported Outcome Measures Tool for Monitoring Toxicities Associated With Systemic Chemotherapy.

Asia-Pacific journal of clinical oncology·2026

Same journal

Correction to "National Clinician Perspectives on Immunotherapy Toxicity: Informing Multidisciplinary Disciplinary Meetings in New Zealand".

Asia-Pacific journal of clinical oncology·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Apr 25, 2026

Driving Simulation in the Clinic: Testing Visual Exploratory Behavior in Daily Life Activities in Patients with Visual Field Defects

Driving Simulation in the Clinic: Testing Visual Exploratory Behavior in Daily Life Activities in Patients with Visual Field Defects

Published on: September 18, 2012

Bespoke treatment: drivers beware!

Sharon Pattison¹, John R Zalcberg

¹Cancer Genetics and Genomics Laboratory, The University of Melbourne, Melbourne, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, Australia; Department of Medicine, The University of Melbourne, Parkville, Victoria, Australia.

Asia-Pacific Journal of Clinical Oncology

|August 27, 2014

Summary

This summary is machine-generated.

Identifying potential driver mutations in tumors is crucial for targeted therapy. However, a mutation

More Related Videos

Robotically Delivered fMRI-Guided Personalized Transcranial Magnetic Stimulation Therapy for Treatment-Resistant Depression

Robotically Delivered fMRI-Guided Personalized Transcranial Magnetic Stimulation Therapy for Treatment-Resistant Depression

Published on: April 10, 2026

Tactile Vibrating Toolkit and Driving Simulation Platform for Driving-Related Research

Tactile Vibrating Toolkit and Driving Simulation Platform for Driving-Related Research

Published on: December 18, 2020

Related Experiment Videos

Last Updated: Apr 25, 2026

Driving Simulation in the Clinic: Testing Visual Exploratory Behavior in Daily Life Activities in Patients with Visual Field Defects

Driving Simulation in the Clinic: Testing Visual Exploratory Behavior in Daily Life Activities in Patients with Visual Field Defects

Published on: September 18, 2012

Robotically Delivered fMRI-Guided Personalized Transcranial Magnetic Stimulation Therapy for Treatment-Resistant Depression

Robotically Delivered fMRI-Guided Personalized Transcranial Magnetic Stimulation Therapy for Treatment-Resistant Depression

Published on: April 10, 2026

Tactile Vibrating Toolkit and Driving Simulation Platform for Driving-Related Research

Tactile Vibrating Toolkit and Driving Simulation Platform for Driving-Related Research

Published on: December 18, 2020

Area of Science:

Oncology
Molecular Biology
Genetics

Background:

Targeted therapy development relies on identifying specific molecular targets.
Advancements in genomic sequencing enable the identification of potential driver mutations in tumors.

Observation:

A case study is presented to illustrate a clinical scenario.
The identified potential driver mutation was not the primary cause of the tumor in this specific case.

Findings:

The presence of a potential driver mutation does not always confirm its role as the key mutational event.
Genomic alterations require careful validation to determine their significance in tumor development.

Implications:

Further research is essential to refine our understanding of tumor genomics.
Accurate identification of key mutational events is necessary for effective and precise targeted cancer therapy.
This case underscores the complexity of cancer genetics and the need for nuanced therapeutic strategies.